Via Financial Statements From 2010 to 2025
| VIAP Stock | | | USD 0.0005 0.00 0.00% |
Analyzing historical trends in various income statement and balance sheet accounts from Via Pharmaceuticals' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Via Pharmaceuticals' valuation are summarized below:
Market Capitalization | Earnings Share |
There are currently one hundred fifteen fundamental trend indicators for Via Pharmaceuticals that can be evaluated and compared over time across competition. Investors and active traders are advised to double-check Via Pharmaceuticals' current fundamental performance against the performance between
2010 and 2025 to make sure the trends are evolving in the right direction. As of 12/26/2025,
Enterprise Value is likely to grow to about 13.9
M, while
Market Cap is likely to drop slightly above 699.5
K.
Check out the analysis of
Via Pharmaceuticals Correlation against competitors.
To learn how to invest in Via Stock, please use our
How to Invest in Via Pharmaceuticals guide.
Via Pharmaceuticals Balance Sheet | | |
|
Via Pharmaceuticals Income Statement | | |
|
Via Pharmaceuticals Cash Flow Statement | | |
|
Financial Ratios | | |
|
Via Pharmaceuticals Valuation Data | | |
|
About Via Pharmaceuticals Financial Statements
Via Pharmaceuticals shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Via Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Via Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Via Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our
fundamental analysis page.
Pair Trading with Via Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Via Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Via Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Via Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Via Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Via Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Via Pharmaceuticals to buy it.
The correlation of Via Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Via Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Via Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Via Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Additional Tools for Via Stock Analysis
When running Via Pharmaceuticals' price analysis, check to
measure Via Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Via Pharmaceuticals is operating at the current time. Most of Via Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Via Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Via Pharmaceuticals' price. Additionally, you may evaluate how the addition of Via Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.